An open-label, randomized, balanced, single oral dose, two-treatment, two-period, two-sequence, two-way, crossover, oral bioequivalence study of Aminocaproic acid Tablets, 1000 mg of Optimus Pharma Private Limited with AMICAR® (aminocaproic acid) Tablets, 1000 mg Marketed by Clover Pharmaceuticals Corp. Marietta, GA 30062 in healthy, adult, human subjects under fed conditions
An open label, randomized, balanced, two treatment, two sequence, two period, truncated, two way cross-over, single-dose, oral bioequivalence study of FDC of Linagliptin 05 mg, Dapagliflozin 10 mg and Metformin Hydrochloride 1000 mg extended release Tablets (T) Manufactured by Optimus Pharma Pvt. Ltd., India with Trajenta® 5 mg (Linagliptin 05 mg) Tablet (R1) Manufactured by West-Ward Columbus Inc., USA and Marketed by Boehringer Ingelheim India Pvt. Ltd., Maharashtra, India and Xigduo® XR (Dapagliflozin and Metformin HCl Extended Release Tablets 10 mg + 1000 mg) (R2) Manufactured by AstraZeneca Pharmaceuticals LP, USA and Imported & Marketed by AstraZeneca Pharma India Ltd., Bangalore, India in normal healthy, adult human subjects under fasting condition.
An Open Label, Randomized, Balanced, Two-Treatment, Two-Sequence, Two-Period, Crossover, Single-Dose, oral bioequivalence study of Brivaracetam Sustained Release Tablets 200 mg (T) Manufactured by Optimus Pharma Pvt. Ltd., India with BRITZILAM SR (Brivaracetam Sustained Release Tablets 200 mg) (R) Manufactured by Ravenbhel Healthcare Pvt. Ltd., India and Marketed by Torrent Pharmaceuticals Ltd., India in healthy, adult, human subjects under fasting conditions.
100 Clinical Results associated with Optimus Pharma Pvt Ltd.
0 Patents (Medical) associated with Optimus Pharma Pvt Ltd.
100 Deals associated with Optimus Pharma Pvt Ltd.
100 Translational Medicine associated with Optimus Pharma Pvt Ltd.